Introduction
Over the last several decades, governments have collectively pledged to slow global warming. But despite intensified diplomacy, the world is already facing the consequences of climate…
Introduction
Throughout its decades of independence, Myanmar has struggled with military rule, civil war, poor governance, and widespread poverty. A military coup in February 2021 dashed hopes for…
During the 2020 presidential campaign, Joe Biden promised that his administration would make a “historic effort” to reduce long-running racial inequities in health. Tobacco use—the leading cause of p…
Rush Doshi is senior fellow for China and Indo-Pacific studies and director of the initiative on China strategy at the Council on Foreign Relations (CFR). His expertise includes China’s foreign polic…
John Kerry discusses his work as U.S. special presidential envoy for climate, the challenges the United States faces, and the Biden administration’s priorities as it continues to address climate chan…
Virtual Event
with John F. Kerry and Michael Froman March 1, 2024
One year after the UN’s high-level meeting on noncommunicable diseases, little progress has been made in generating momentum and new resources. But with the right focus and strategies, there is room to move forward, says CFR’s Thomas Bollyky.
Global health needs are changing. A new set of global health challenges, from diabetes, cancer, and other non-communicable diseases (NCDs) to traffic injuries, are overtaking infectious diseases as major causes of premature disability and death worldwide. Please join us for a discussion of these new global health challenges arising in low- and middle-income countries and the scalable, practical strategies that can help address them.
Experts discuss scalable and practical strategies developing countries can use to address the global health challenges of noncommunicable diseases.
This session is part two of the two session meeting, Noncommunicable Diseases and the New Global Health.
Overview
Though developed countries have made great strides in tobacco control, tobacco use is increasing in many developing countries due to higher incomes, aggressive marketing by multinational …
The 2011 high-level UN meeting on non-communicable diseases fell far short of the major funding and targets agreed to at a similar meeting on HIV/AIDS a decade ago, which CFR’s Thomas Bollyky says indicates a need for different actors and approaches on chronic diseases.
NCDs such as cancer and heart disease are becoming leading causes of death in the developing world and will be the focus of a September UN meeting. But health experts and others are divided about how much funding should go into a global campaign aimed at preventing NCDs and whether infectious disease programs will suffer as a result.
Derek Yach, director of global health policy at PepsiCo, discusses the role of government and business in lowering mortality rates from non-communicable diseases (NCDs). "We now have overwhelming evidence, both of the health impact, and perhaps as importantly, we’re starting to see the economic impact of heart disease, diabites, chronic lung disease, cancer," says Yach, arguing this data is raising global interest in the issue of NCDs.
Explainer Videowith Derek Yach and Toni Johnson September 12, 2011
Tobacco is reemerging as a polarizing issue in U.S. trade policy. New trade agreement negotiations, the first launched by the Obama administration, and an upcoming UN summit on noncommunicable diseas…
This September the United Nations will convene a high level summit on prevention and control of non-communicable diseases (NCDs), including cardiovascular disease, cancer, chronic lung diseases, and diabetes. Please join us for a discussion on the extent and source of the NCD problem, and the goals of the upcoming summit.
Experts discuss the importance of prevention and control of non-communicable diseases, as well as the need for the United States and the United Nations to play a larger role.
Council of Councils
Think Global Health
Online Store